StockData
SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31

DNA X, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$3.31+0.04 (+1.22%)

Close on Oct 19, 2026

Market cap
$4.47M
P/E (TTM)
–
Dividend yield
–

DNA X, Inc. cash flow statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
302.6%

Financial strength

Current ratio
0.57
Debt to equity
–
Debt to assets
–
Cash to current liabilities
17.5%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–